Pasar al contenido principal

POTENCIAL TERAPEUTICO DE NUEVOS INHIBIDORES DE LA ACTIVIDAD COLINA QUINASA. REPERCUSION EN EL METABOLISMO LIPIDICO: ESTRATEGIA DE AMPLIO ESPECTRO CONTRA EL CANCER

PID2019-109294RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biological evaluation as antimalarial of two families of biscationic compounds featuring two different sulphur linkers

  • Luque Navarro, Pilar María
  • Carrasco-Jiménez, María Paz
  • Parisini, Emilio
  • Lanari, D.
  • Odina, Laura M.
  • Jekabsons, A
  • Perales, Sonia
  • Zelencova-Gopejenko, Diana
  • Pérez-Moreno, Guiomar
  • Bosch-Navarrete, Cristina
  • González-Pacanowska, Dolores
  • López-Cara, Luisa C.
Plasmodium falciparum kinases have been widely studied due to their potential as targets for the discovery of alternatives to artemisinin-combined therapies. Their role in parasite blood-stage replication and their homology with human kinases has led to the exploitation of already tested antitumoral kinase inhibitors as antiplasmodial drugs. Plasmodium falciparum choline kinase (PfCK), a cytosolic enzyme involved in phospholipid synthesis, is a promising target for parasite resistant strains. PfCK uses the host choline and catalyzes its transformation in phosphocholine, a key step for the formation of the lipid membranes required by the new parasite progeny inside the erythrocyte. Previously, we described the synthesis of two libraries (PL and FP) of human choline kinase (hCK) inhibitors, which we generated following a green by design approach. Some of these compounds were found to exhibit antitumoral properties. Here, we evaluated the same compounds as potential inhibitors of PfCK and antimalarial agents. Interestingly, while the compounds of the FP library, which feature a disulphide linker, show PfCK inhibition in the nM range independently of the cationic head (FP3 being the most active compound, PfCK IC<inf>50</inf> = 0.16 μM), they show no effect on infected erythrocytes. On the other hand, the compounds of the PL library, which feature a dithioethane linker, show in vitro activity against the parasite but no inhibitory activity against the isolated enzyme (PL40 exhibits the highest antimalarial activity, with IC<inf>50</inf> = 10 nM). This lack of correlation could be due to either cellular disulphide degradation in vitro or to the existence of alternative targets for the dithioethane library. Considering the previously reported anticancer potential of the PL family and the antiparasitic activity reported herein, these compounds may be considered as good starting points for the development of multifunctional drugs., This research was funded by Convocatoria 2019 Proyectos de I + D + i − RTI Tipo B “Ministerio de Innovacion y Ciencia” grant number PID2019-109294RB-I00 funded by MCIN/ AEI/10.13039/501100011033 and “Convocatoria 2020 Proyectos I + D + i del Programa Operativo FEDER 2020”, grant number B-CTS-216- UGR20. E.P. thanks the ERDF project BioDrug (No. 1.1.1.5/19/A/004). The work was also funded by the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), grant PID2022-142971OB-I00, funded by MCIN/AEI/ 10.13039/501100011033/FEDER, UE and by the Junta de Andalucía (BIO-199 and CTS-236). The authors thank the Granada University Library for its financial support. The authors thank the Centro de Supercomputación de la Universidad de Granada (CSIRC) for the computing resources., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors

  • Schiaffino-Ortega S.
  • Mariotto E.
  • Luque-Navarro P.M.
  • Kimatrai-Salvador M.
  • Rios-Marco P.
  • Hurtado-Guerrero R.
  • Marco C.
  • Carrasco-Jimenez M.P.
  • Viola G.
  • López-Cara L.C.
Choline kinase inhibitors are an outstanding class of cytotoxic compounds useful for the treatment of different forms of cancer since aberrant choline metabolism is a feature of neoplastic cells. Here, we present the most in-depth structure-activity relationship studies of an interesting series of non-symmetric choline kinase inhibitors previously reported by our group: 3a–h and 4a–h. They are characterized by cationic heads of 3-aminophenol bound to 4-(dimethylamino)-or 4-(pyrrolidin-1-yl)pyridinium through several linkers. These derivatives were evaluated both for their inhibitory activity on the enzyme and their antiproliferative activity in a panel of six human tumor cell lines. The compounds with the N-atom connected to the linker (4a–h) show the best inhibitory results, in the manner of results supported by docking studies. On the contrary, the best antiproliferative compounds were those with the O-atom bounded to the linker (3a–h). On the other hand, as was predictable in both families, the inhibitory effect on the enzyme is better the shorter the length of the linker. However, in tumor cells, lipophilicity and choline uptake inhibition could play a decisive role. Interestingly, compounds 3c and 4f, selected for both their ability to inhibit the enzyme and good antiproliferative activity, are endowed with low toxicity in non-tumoral cells (e.g., human peripheral lymphocytes) concerning cancer cells. These compounds were also able to induce apoptosis in Jurkat leukemic cells without causing significant variations of the cell cycle. It is worth mentioning that these derivatives, besides their inhibitory effect on choline kinase, displayed a modest ability to inhibit choline uptake thus suggesting that this mechanism may also contribute to the observed cytotoxicity.